153 related articles for article (PubMed ID: 17188756)
1. Neurodegeneration and -protection in autoimmune CNS inflammation.
Diem R; Sättler MB; Bähr M
J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
[TBL] [Abstract][Full Text] [Related]
2. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas O; Waiczies S; Zipp F
J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
[TBL] [Abstract][Full Text] [Related]
3. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
Hauser SL; Oksenberg JR
Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Ellwardt E; Zipp F
Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
[TBL] [Abstract][Full Text] [Related]
5. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis.
Diem R; Taheri N; Dietz GP; Kuhnert A; Maier K; Sättler MB; Gadjanski I; Merkler D; Bähr M
Neurobiol Dis; 2005 Nov; 20(2):218-26. PubMed ID: 16242630
[TBL] [Abstract][Full Text] [Related]
6. Future neuroprotective strategies.
Sättler MB; Bähr M
Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of neurodegeneration in multiple sclerosis.
Lassmann H; van Horssen J
FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
[TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Reichardt HM; Gold R; Lühder F
Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of neurodegeneration and CNS inflammation.
Olsson T; Piehl F; Swanberg M; Lidman O
J Neurol Sci; 2005 Jun; 233(1-2):99-108. PubMed ID: 15894332
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: a battle between destruction and repair.
McQualter JL; Bernard CC
J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
[TBL] [Abstract][Full Text] [Related]
12. New insights into adaptive immunity in chronic neuroinflammation.
Siffrin V; Brandt AU; Herz J; Zipp F
Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
[TBL] [Abstract][Full Text] [Related]
13. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
Inglese M; Benedetti B; Filippi M
J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
[TBL] [Abstract][Full Text] [Related]
14. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration in multiple sclerosis: defining the problem.
Lisak RP
Neurology; 2007 May; 68(22 Suppl 3):S5-12; discussion S43-54. PubMed ID: 17548569
[TBL] [Abstract][Full Text] [Related]
16. Advancement of therapies for neuroprotection in multiple sclerosis.
Lo A
Expert Rev Neurother; 2008 Sep; 8(9):1355-66. PubMed ID: 18759548
[TBL] [Abstract][Full Text] [Related]
17. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
Wang C; Slikker W
Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
[TBL] [Abstract][Full Text] [Related]
18. Death ligands and autoimmune demyelination.
Aktas O; Prozorovski T; Zipp F
Neuroscientist; 2006 Aug; 12(4):305-16. PubMed ID: 16840707
[TBL] [Abstract][Full Text] [Related]
19. Bladder dysfunction in multiple sclerosis.
McCombe PA; Gordon TP; Jackson MW
Expert Rev Neurother; 2009 Mar; 9(3):331-40. PubMed ID: 19271942
[TBL] [Abstract][Full Text] [Related]
20. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
Karussis D; Kassis I
Clin Neurol Neurosurg; 2008 Nov; 110(9):889-96. PubMed ID: 18375051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
